IFLO and THRX Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO and THRX

THRX 9.810

+0.4%

Jan 8 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brian Nichols who wrote (17)	6/2/1996 1:02:00 AM
From: Brian Malloy	of 68

From one Brian to another, Yes, I Flow will be a $13 stock and then some, although I don't know if I would look for that in nine to twelve months. IFLO is fairly valued at this point. Due to marketing agreements we have a known baseline cashflow into the company through 1998. To push the stock further, we must look for a. news that the recent acquisition of the company which makes reusable medical devices is working well. What is their ROE? b. We need to hear that final trials and FDA approval are complete for new products in IFLO pipeline, then wait six months after fielding to determine if the new products will be succesful in the marketplace. nine to twelve months, I see $8.00/share. Then if a and b listed above occur then expect a pop to $13-15 range. Also, if the use of IFLO products takes off in Europe and or Central and South America in 1997 then expect even more. Brian Malloy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next